Genencor
Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of DuPont. Genencor is a leading producer of Industrial enzymes and low-priced bulk protein. The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982. It is considered to have pioneered the field of industrial biotechnology, as distinct from traditional applications of biotechnology to health care and agriculture.
 | |
| Private | |
| Industry | Biotechnology |
| Founded | 1982 |
| Headquarters | Palo Alto, California, United States, Palo Alto |
Key people | Tjerk de Ruiter, Chairman & CEO Michael Arbige, Vice President, Technology Jim Sjoerdsma, Sr. Vice President, Human Resources David Estell, Vice President, innovation |
| Products | Purafect, Properase, Spezyme |
| Revenue |  |
Number of employees | 1,500 (2005) |
| Parent | DuPont |
| Website | http://biosciences.dupont.com// |
In 2005 Genencor was acquired by Danisco.[1]
In 2008 Genencor entered a joint venture with DuPont, called DuPont Danisco Cellulosic Ethanol LLC, to develop and commercialize low cost technology for the production of cellulosic ethanol. In 2008, Genencor and Goodyear announced they were working to develop BioIsoprene.
In 2011, Dupont acquires [2]Danisco for $6.3 billion.
Awards
Genencor achieved the following awards:
- Named No. 2 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2004)
- Named No. 1 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2005)
- Named No. 1 Best Place to Work in the Bay Area by the San Francisco Chronicle (2005)
- Named No. 11 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2011)
References
- Danisco acquire Genencor for $419 million
- DuPont. "DuPont to Acquire Danisco for $6.3 Billion". www.prnewswire.com. Retrieved 2019-07-11.